Clinical Trials

Penn Study Finds About 30% Lower Breast Cancer Incidence Among Women Prescribed GLP‑1 Drugs

Researchers say weight loss and metabolic changes may explain the link as they move to launch multisite randomized trials to test whether the drugs can prevent breast cancer